[ Price : $8.95]
FDA cautions BioCorRx about false and misleading information on the Web site home page for its Lucemyra.[ Price : $8.95]
Vanda Pharmaceuticals says FDA should withdraw a legislative proposal in its budget package that the company says would lengthen N...[ Price : $8.95]
FDA and the device industry are nearing a final agreement on the next round of Medical Device User Fee Act (MDUFA VI) negotiations...[ Price : $8.95]
Medline Industries recalls (Class 1) its angiographic control syringes, warning the devices could cause severe injury or death.[ Price : $8.95]
FDA removes partial clinical hold against MacroGenics Phase 2 LINNET study evaluating the investigational cancer therapy lorigerli...[ Price : $8.95]
An FDA Matters column calls on FDA to fully enforce the laws against mass compounding of approved drugs that are not in shortage.[ Price : $8.95]
Law firm Sheppard breaks down some of FDAs proposals in its budget documents that industry should keep a close eye on, including n...[ Price : $8.95]
FDA announces a 5/18 virtual public workshop aimed at advancing the use of novel surrogate endpoints in developing treatments for ...